Edmars Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 03-12-2024
- Paid Up Capital ₹ 0.36 M
as on 03-12-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -33.88%
(FY 2022)
- Ebitda -28.14%
(FY 2022)
- Net Worth -12.80%
(FY 2022)
- Total Assets 255.65%
(FY 2022)
About Edmars Pharma
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.36 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Ghosh, Sukanta Atta, Abhijit Das, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51397WB2020PTC236291
- Company No.
236291
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Howrah, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Edmars Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Ghosh  | Director | 05-Feb-2020 | Current |
| Sukanta Atta | Director | 07-May-2021 | Current |
| Abhijit Das | Director | 22-Sep-2022 | Current |
| Tanmay Panday | Director | 22-Sep-2022 | Current |
| Prabir Bhowmik | Director | 22-Sep-2022 | Current |
Financial Performance of Edmars Pharma.
Edmars Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 33.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Edmars Pharma?
Unlock access to Edmars Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Celrox Health Care Private LimitedActive 1 year 5 months
Rajesh Ghosh, Abhijit Das and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Edmars Pharma?
Unlock and access historical data on people associated with Edmars Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edmars Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edmars Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
